As curcumin exhibited an inhibitory effect on the CXCL12/CXCR4 axis and the NF-κB signaling pathway in MCF7 cells, it was demonstrated that curcumin has the potential to modulate breast cancer TME by repressing both ADMSCs and cancer cells. This evidence concerns the gene CXCL12 and breast cancer.